Biscayne NeuroTherapeutics
VerifiedBiscayne Pharmaceuticals discovers and develops novel therapies based on growth hormone-releasing hormone (GHRH) analogs.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$185m (Public information from Sep 2018)
Miami Florida (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | $0.0 | round |
| investor investor | $0.0 | round | |
$185m Valuation: $185m | Acquisition | ||
| Total Funding | 000k | ||
Related Content
Recent News about Biscayne NeuroTherapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.